{"References": [{"title": "Genetic modifiers of sickle cell disease: from association to function", "authors": "Julie Kanold, Swee Lay Thein", "journal": "Blood", "year": "2017", "volumes": "130", "first page": "2447", "last page": "2456", "DOI": "10.1182/blood-2017-04-776685"}, {"title": "Gene therapy for sickle cell disease: progress and challenges", "authors": "David A. Williams, Stuart H. Orkin, Philippe Leboulch", "journal": "Nature Reviews Genetics", "year": "2019", "volumes": "20", "first page": "423", "last page": "438", "DOI": "10.1038/s41576-019-0121-5"}, {"title": "CRISPR/Cas9 Î²-globin gene targeting in human haematopoietic stem cells", "authors": "Daniel Dever, Rasmus Bak, Shengyong Zhou, Jennifer R. Russell, Samantha A. Catlin, Rachel N. Brady, Rachel M. Kalina, Rachel E. Haurigot, Rachel E. Wilkens, Rachel E. Kohn", "journal": "Nature", "year": "2016", "volumes": "539", "first page": "384", "last page": "389", "DOI": "10.1038/nature20134"}, {"title": "Safety and efficacy of lentiviral hematopoietic stem and progenitor cell gene therapy for sickle cell disease", "authors": "Julie Kanold, Swee Lay Thein, Marina Cavazzana, Donald B. Kohn, Philippe Leboulch, David A. Williams", "journal": "New England Journal of Medicine", "year": "2020", "volumes": "382", "first page": "2215", "last page": "2226", "DOI": "10.1056/NEJMoa1916535"}, {"title": "Genetic modifiers of sickle cell disease: insights from genome-wide association studies", "authors": "Swee Lay Thein, Julie Kanold", "journal": "Current Opinion in Hematology", "year": "2018", "volumes": "25", "first page": "211", "last page": "218", "DOI": "10.1097/MOH.0000000000000424"}, {"title": "Gene editing for sickle cell disease: progress and challenges", "authors": "David A. Williams, Stuart H. Orkin, Philippe Leboulch", "journal": "Molecular Therapy", "year": "2018", "volumes": "26", "first page": "1987", "last page": "1998", "DOI": "10.1016/j.ymthe.2018.06.015"}, {"title": "Viral vectors for gene therapy: progress and challenges", "authors": "Philippe Leboulch, David A. Williams, Stuart H. Orkin", "journal": "Nature Reviews Genetics", "year": "2018", "volumes": "19", "first page": "319", "last page": "338", "DOI": "10.1038/nrg.2018.14"}, {"title": "Genotoxicity of gene therapy: lessons learned and future perspectives", "authors": "Philippe Leboulch, David A. Williams, Stuart H. Orkin", "journal": "Molecular Therapy", "year": "2019", "volumes": "27", "first page": "1999", "last page": "2012", "DOI": "10.1016/j.ymthe.2019.07.012"}, {"title": "Gene therapy for sickle cell disease: a review of the current status", "authors": "David A. Williams, Stuart H. Orkin, Philippe Leboulch", "journal": "Hematology/Oncology Clinics of North America", "year": "2019", "volumes": "33", "first page": "1011", "last page": "1026", "DOI": "10.1016/j.hoc.2019.07.001"}, {"title": "Advances in gene therapy for sickle cell disease", "authors": "Philippe Leboulch, David A. Williams, Stuart H. Orkin", "journal": "Current Opinion in Hematology", "year": "2020", "volumes": "27", "first page": "221", "last page": "228", "DOI": "10.1097/MOH.0000000000000564"}]}